drugset / Trial / NCT05768243

Hyaluronic Acid Versus Red Injectable Platelet Rich Fibrin in Treatment of Periodontitis

NCT05768243

Phase 4 Completed 75 enrolled Beirut Arab University
RandomizedParallel-groupDouble-blindTreatment

Summary

the aim of this clinical trial is to compare the efficacy of hyaluronic acid (HA) used as an adjunctive to scaling and root planing (SRP) and red injectable platelet rich-fibrin (i-PRF) in the non-surgical treatment of stage III periodontitis. The main question it aims to answer is: is there a difference between HA and red i-prf when used as an adjunct to SRP in terms of efficacy? Participants who are eligible will be assigned to one of the treatment groups: * Group 1= receives HA+ SRP * Group 2= receives red i-prf + SRP * Group 3= receives only SRP Researchers will compare Groups 1,2 and 3 to see if there's a difference in the periodontal parameters measured.

Timeline

Start
2021-03-01
Primary completion
2022-07-24
Completion
2022-09-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 0.2 ml Other
Subject Hyaluronic Acid Other / unclassified 1 ml Other

Indications